XPeng Inc.
NYSE:XPEVAuto - Manufacturers
-$0.40 today
- Market cap
- $9.25B
- Beta
- 1.08
- P/E (TTM)
- -37.8
- EPS (TTM)
- -$1.18
Volume 8.06M
Average 6.75M
XPEV EBITDA Margin
EBITDA as a percentage of revenue.
XPeng Inc.NYSE: XPEV
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to -3.0%
EBITDA Margin was -3.0% in Q3 FY2026, down 1.6 pp from a year earlier. On a trailing-twelve-month basis it was -4.0%, down 0.5 pp year over year. Over 3 fiscal years it widened by 31.1 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 13 analysts of 3.8% for the fiscal year ending Dec 2026, up from 2.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -3.0%+3.7 pp QoQ
- Last fiscal yearDec 2025
- 2.9%+10.0 pp YoY
- LTMSep 2026
- -4.0%-0.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.6 pp | +1.2 pp | +2.7 pp |
| 1 year | +10.0 pp | +0.9 pp | -9.1 pp |
| 3 years | +31.1 pp | +4.1 pp | -27.0 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 2.9%
- Year-over-year change
- +10.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.9% | +10.0pp |
| FY2024 | 2024-12-31 | -7.1% | +19.0pp |
| FY2023 | 2023-12-31 | -26.1% | +2.1pp |
| FY2022 | 2022-12-31 | -28.2% | -9.4pp |
| FY2021 | 2021-12-31 | -18.8% | — |
EBITDA Margin vs competitors
How XPEV compares with its peers on the latest reported figures
- XPEV's LTM Sep 2026 EBITDA Margin of -4.0% is the 7th highest of the 11 companies compared; the peer median is -2.7%.
- Its year-over-year change of -0.5 pp is the 6th highest of 11, against a peer median of +3.2 pp.
- Over three fiscal years its change of +31.1 pp compares with a peer median of +11.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 14.2% | -2.5 pp | -0.2 pp | |
| LTM Sep 2026 | 10.9% | -2.9 pp | -9.0 pp | |
| LTM Sep 2026 | 8.0% | -2.0 pp | -5.3 pp | |
| LTM Jun 2026 | -0.9% | -7.0 pp | -5.4 pp | |
| LTM Jun 2026 | -2.4% | -11.7 pp | +7.3 pp | |
| LTM Jun 2026 | -3.0% | +17.4 pp | +15.2 pp | |
| LTM Sep 2026 | -4.0% | -0.5 pp | +31.1 pp | |
| LTM Jun 2026 | -36.4% | +8.5 pp | +313.9 pp | |
| LTM Dec 2025 | -69.2% | +35.6 pp | +7128.2 pp | |
| LTM Mar 2026 | -75.4% | +12.1 pp | +198.5 pp | |
| LTM Mar 2026 | -197.5% | +36.7 pp | +16.4 pp | |
| Peer median (excluding XPEV) | -2.7% | +3.2 pp | +11.3 pp | |
Competitors are the stored peer set for XPEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 20.99B | 26.86B | 30.68B | 40.87B | 76.72B |
| Cost of Revenue | 18.37B | 23.77B | 30.22B | 35.02B | 62.25B |
| Gross Profit | 2.62B | 3.09B | 451.16M | 5.85B | 14.47B |
| Gross Margin | 12.5% | 11.5% | 1.5% | 14.3% | 18.9% |
| Research & Development | 4.11B | 5.21B | 5.28B | 6.46B | 9.49B |
| Selling, General & Admin | 5.31B | 6.69B | 6.56B | 6.87B | 9.4B |
| Operating Expenses | 9.2B | 11.79B | 11.34B | 12.5B | 17.13B |
| Depreciation & Amortization | 837.8M | 1.41B | 2.11B | 2.57B | 2.99B |
| EBITDA | (3.94B) | (7.58B) | (8.02B) | (2.91B) | 2.21B |
| EBITDA Margin | -18.8% | -28.2% | -26.1% | -7.1% | 2.9% |
| Operating Income | (6.58B) | (8.71B) | (10.89B) | (6.66B) | (2.65B) |
| Operating Margin | -31.3% | -32.4% | -35.5% | -16.3% | -3.5% |
| Interest Income | 743.03M | 1.06B | 1.26B | 1.37B | 1.16B |
| Interest Expense | 55.34M | 132.19M | 268.67M | 343.98M | 379.93M |
| Other Income / Expenses | 1.74B | (408.72M) | 550.47M | 798.09M | 1.53B |
| Income Before Tax | (4.84B) | (9.11B) | (10.34B) | (5.86B) | (1.13B) |
| Pre-Tax Margin | -23.0% | -33.9% | -33.7% | -14.3% | -1.5% |
| Income Tax Expense | 25.99M | 24.73M | 36.81M | (69.78M) | 13.59M |
| Net Income | (4.86B) | (9.14B) | (10.38B) | (5.79B) | (1.14B) |
| Net Margin | -23.2% | -34.0% | -33.8% | -14.2% | -1.5% |
| EPS (Basic) | (5.92) | (10.68) | (11.92) | (6.12) | (2.40) |
| EPS (Diluted) | (5.92) | (10.68) | (11.92) | (6.12) | (2.40) |
| Weighted Avg Shares | 821.45M | 856.27M | 870.46M | 945.68M | 476M |
| Weighted Avg Shares (Diluted) | 821.45M | 856.27M | 870.46M | 945.68M | 476M |
XPeng Inc.
NYSE:XPEV
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.